CUSIP: 14757U109
Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
2,993,802
-
Share change
-
-223,945
-
Total reported value
-
$4,027,053
-
Price per share
-
$1.33
-
Number of holders
-
23
-
Value change
-
-$304,187
-
Number of buys
-
7
-
Number of sells
-
5
Quarterly Holders Quick Answers
What is CUSIP 14757U109?
CUSIP 14757U109 identifies CASI - CASI PHARMACEUTICALS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2015
-
Previous quarter:
Q3 2014
Recent filing periods for CUSIP 14757U109:
Institutional Holders of CASI PHARMACEUTICALS INC - COM (CASI) as of Q4 2014
As of 31 Dec 2014,
CASI PHARMACEUTICALS INC - COM (CASI) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,993,802 shares.
The largest 10 holders included
SABBY MANAGEMENT, LLC, Wellington Shields Capital Management, LLC, Wellington Shields & Co., LLC, VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, Moors & Cabot, Inc., GEODE CAPITAL MANAGEMENT, LLC, BlackRock Fund Advisors, and DIMENSIONAL FUND ADVISORS LP.
This page lists
23
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.